Centessa Pharmaceuticals Shares Down 4.5 percent Time to Sell?
WAI Stock | 0.37 0.08 17.78% |
Under 64% of Top KingWin's investor base is looking to short. The analysis of overall sentiment of trading Top KingWin stock suggests that many investors are alarmed at this time. Top KingWin's investing sentiment shows overall attitude of investors towards Top KingWin.
Top |
Centessa Pharmaceuticals plc shares traded down 4.5 percent on Friday . The stock traded as low as 17.38 and last traded at 17.38. 600,342 shares traded hands during trading, an increase of 46 percent from the average session volume of 411,010 shares. The stock had previously closed at 18.19. Analyst Ratings Changes
Read at thelincolnianonline.com
Top KingWin Fundamental Analysis
We analyze Top KingWin's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Top KingWin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Top KingWin based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Top KingWin is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Top KingWin Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Top KingWin stock to make a market-neutral strategy. Peer analysis of Top KingWin could also be used in its relative valuation, which is a method of valuing Top KingWin by comparing valuation metrics with similar companies.
Peers
Top KingWin Related Equities
LPCN | Lipocine | 10.00 | ||||
CNTA | Centessa Pharmaceuticals | 1.00 | ||||
VALN | Valneva SE | 0.52 | ||||
STKL | SunOpta | 0.26 | ||||
MRRTY | Marfrig Global | 0.97 | ||||
ABOS | Acumen Pharmaceuticals | 2.98 | ||||
MNMD | Mind Medicine | 7.99 |
Complementary Tools for Top Stock analysis
When running Top KingWin's price analysis, check to measure Top KingWin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Top KingWin is operating at the current time. Most of Top KingWin's value examination focuses on studying past and present price action to predict the probability of Top KingWin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Top KingWin's price. Additionally, you may evaluate how the addition of Top KingWin to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |